Organogenesis Holdings Inc. Files Q1 2025 10-Q
Ticker: ORGO · Form: 10-Q · Filed: May 8, 2025 · CIK: 1661181
| Field | Detail |
|---|---|
| Company | Organogenesis Holdings INC. (ORGO) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financial-reporting, quarterly-results
TL;DR
Organogenesis 10-Q filed: Q1 2025 financials and biz updates out.
AI Summary
Organogenesis Holdings Inc. filed its 10-Q for the period ending March 31, 2025. The company reported on its financial performance and business operations. Key financial details and operational updates are included in this filing.
Why It Matters
This filing provides investors with an update on Organogenesis' financial health and strategic direction for the first quarter of 2025.
Risk Assessment
Risk Level: medium — The filing contains standard financial reporting for a public company, but specific financial performance details and forward-looking statements would determine the ultimate risk.
Key Numbers
- 20250331 — Period End Date (The financial data in this report pertains to this date.)
- 20250508 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Organogenesis Holdings Inc. (company) — Filer of the 10-Q
- Avista Healthcare Public Acquisition Corp. (company) — Former name of Organogenesis Holdings Inc.
- 20250331 (date) — Conformed period of report
- 20250508 (date) — Filed as of date
- 0000950170-25-066962 (other) — Accession number for the filing
FAQ
What is the reporting period for this 10-Q filing?
The conformed period of report is March 31, 2025.
When was this 10-Q filing submitted to the SEC?
The filing was submitted on May 8, 2025.
What was Organogenesis Holdings Inc. formerly known as?
The company was formerly known as Avista Healthcare Public Acquisition Corp.
What is the Standard Industrial Classification code for Organogenesis Holdings Inc.?
The SIC code is 2834, Pharmaceutical Preparations.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Organogenesis Holdings Inc. (ORGO).